United StatesThe U.S. Food and Drug Administration (FDA) has approved bemotrizinol, a new active sunscreen ingredient that provides broad-spectrum protection against both ultraviolet A (UVA) and B (UVB) rays. This marks the first new sunscreen ingredient approved in the U.S. since 1999. Dermatologists are excited about its potential benefits, including its photostability—meaning it remains effective under sunlight—and its ability to blend well into sunscreen formulations, reducing the 'white cast' effect. The ingredient has been used safely for decades in other regions like Europe and Asia. While concerns have been raised online about other sunscreen chemicals like oxybenzone potentially affecting hormone function, these claims lack evidence in human studies.
Bias read (Center): The article presents factual information about the FDA's approval of a new sunscreen ingredient and includes quotes from dermatologists highlighting its benefits. It does not take a clear stance on any political issue, nor does it exhibit biased language or selective sourcing. The content focuses on
